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Abstract
Background: Ultrasound guidance has reduced the amount of local anesthetics to achieve a successful block.
Previous studies of the relationship between the volume or concentration of local anesthetics and the effects of the
block were based on relatively high doses of local anesthetics. We tested the hypothesis that providing low dose of
ropivacaine at three combinations of volumes and concentrations for ultrasound-guided interscalene brachial
plexus block would produce different effects in the aspect of onset time, pain control and the incidence of side
effects.
Methods: Ninety-nine patients undergoing elective arthroscopic shoulder surgery were randomized to receive an
ultrasound guided combined with nerve stimulator mediated interscalene block with ropivacaine 0.75 % (6.7 ml,
Group 0.75), 0.5 % (10 ml, Group 0.5) or 0.25 % (20 ml, Group 0.25). The primary end point was the onset time of
the sensory blockade, assessed by using a pinprick in the C5-6 dermatome. The secondary end points included the
onset time of the motor blockade, block success rate, postoperative pain rating score, rescue analgesics
requirement, sleep quality, strength of the hand on the block side,and the incidence of hemi-diaphragmatic paresis
which was evaluated by ultrasonography.
Results: There was a statistically significant difference of the sensory block median onset times among Group 0.75
(5 min), Group 0.5 (10 min) and Group 0.25 (20 min). One patient in Group 0.5 and 20 patients in Group 0.25 did
not achieve a complete motor block within 30 min, which were also significantly different. No significant difference
was observed in postoperative analgesia, decrease of handgrip strength and the incidence of hemi-diaphragmatic
paresis among the 3 groups.
Conclusions: This study demonstrates that ropivacaine 50 mg as 0.25, 0.5 or 0.75 % solution for interscalene
brachial plexus block before arthroscopic shoulder surgery produces comparable blockade with few side effects,
while 0.75 % seems to be more preferable as it is associated with faster onset time.
Trial registration: ChiCTR-TRC-13004058. Registered 4 December 2013.
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Background
Interscalene brachial plexus block (ISBPB) is one of
the most reliable and the most commonly performed
techniques to control intra and postoperative pain
[1, 2]. Ultrasound guidance with or without nerve stimu-
lator has reduced the amount of local anesthetics (LA) to
achieve a successful block, which may minimize complica-
tions of ISBPB. Previous studies have suggested that
ISBPB with 27 mg of 0.75 % or 25 mg of 0.5 or 0.25 %
low-dose ropivacaine were effective to achieve sensory
and motor block for arthroscopic shoulder surgery [3–5].
Although low dose ropivacaine with the concentration
arranging from 0.25 to 0.75 % has been used in ISBPB
[3–5], the optimal combination of concentration and
volume of such low dose has not been studied. Previous
studies have used a fixed large dose of LA in different
volumes and concentrations for a sciatic nerve block [6,
7], infraclavicular block [8], axillary block [9, 10], and
humeral canal block [11]. The results of these studies
with the respects of onset time, successful rate and block
duration were not consistent. Various factors, including
the technique used, the anatomic aspects of the injection
and the pharmacodynamics aspect of LA may influence
the results.
The ideal concentration-volume ratio for low dose
ISBPB needs further study. We tested the hypothesis
that 50 mg ropivacaine of three combinations of vol-
umes and concentrations for ultrasound-guided ISBPB
produces different effects in the aspect of onset time,
pain control and the incidence of side effects.
Methods
Following institutional review board approval (Peking
University Third Hospital Ethics Committee) and trial
registration (ChiCTR-TRC-13004058), patients sched-
uled for elective arthroscopic shoulder surgery were re-
cruited in this prospective, randomized, controlled,
double blind clinical trial. Written informed consents
were obtained from all patients.
The inclusion criteria were age between 18 and
80 years and an American Society of Anesthesiologists
physical status of I and II. The exclusion criteria were
patient refusal, neurologic or neuromuscular disease, se-
vere bronchopulmonary disease, coagulation disorders,
infection at the injection site, known allergy to one or
more medications used in the study protocol, body mass
index over 32 kg/m2 and patients treated with opioid
analgesics.
Using a computer generated random number table,
patients were randomized into three groups: 6.7 ml of
0.75 % ropivacaine (Group 0.75), 10 ml of 0.5 % ropiva-
caine (Group 0. 5) and 20 ml of 0.25 % ropivacaine
(Group 0.25). Sealed opaque envelopes with the study
group allocation were opened before the blocks were
performed. An independent anesthesiologist who was
not involved in the study prepared the study solution.
Routine monitors (pulse oximeter, noninvasive blood
pressure cuff, and electrocardiogram) were used, and
intravenous access was established. Patients were preme-
dicated intravenously with midazolam 2 mg and dexa-
methasone 10 mg.
After skin disinfection and infiltration with lidocaine
1 %, the scalene muscles and interscalene brachial plexus
were imaged in the short axis using a 38-mm 13–6 MHz
linear array ultrasound probe (Turbo SonoSite HFL,
Bothell, WA), the transverse process of vertebra C7 was
identified by the absence of the anterior tubercle, subse-
quently, root C7 of the brachial plexus was visualized in
short-axis view, then move the probe to detect root C6
and C5. After clear identification of root C6 and C5,
then the area posterior to the plexus was analysed for
the presence of the dorsal scapular and long thoracic
nerves located within or around the middle scalene
muscle as a discrete hyperechoic structure containing
hypoechoic fascicles within them. Then a short bevel
100-mm, 19-gauge stimulating needle (StimuLong Sono
Tsui set, Pajunk, Geisingen, Germany) connected to a
Stimuplex (Stimuplex-HNS II A; B. Braun Melsungen
AG, Germany) nerve stimulator was inserted using an
in-plane technique from posterior to the probe, follow-
ing a shallower needle trajectory to avoid entering the
bulk of middle scalene muscle. If the dorsal scapular and
long thoracic nerves had been visualized within the mid-
dle scalene, avoid injuring them during the needle pas-
sage. But if they were hard to identify by ultrasound,
during inserting the stimulating needle, the contractions
of the serratus anterior, rhomboids, and levator scapulae
could help identify the dorsal scapular (rhomboids and
levator scapulae muscle) or long thoracic (serratus anter-
ior muscle), and once these muscle twitches were ob-
served, stop and change the needle passage to avoid
nerve injury. Elicitation of a sustained deltoid motor re-
sponse at 0.3–0.5 mA with the tip of the needle posi-
tioned just lateral to the C5-6 roots confirmed the
correct placement of the needle. All injections were
administered slowly with repeated aspiration to prevent
or detect early intravascular injection. The blocks were
performed by an experienced physician who specialized
in ultrasound and nerve stimulation–assisted intersca-
lene block. After completion of the block, all the evalua-
tions were performed by another blinded independent
observer who was not involved in grouping, study solu-
tion preparing and interscalene block performing. All
patients were blind to their group throughout the study.
Sensory and motor blockades were assessed every
5 min for up to 30 min. Sensory blockade was assessed
by using a pinprick in the C5-6 dermatome (lateral re-
gion of the arm, innervated by the superior cutaneous
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nerve of the arm, branch of the axillary nerve) on a 3-
point verbal rating scale: 0, normal sensation; 1, dull sen-
sation (analgesia); and 2, no sensation (anesthesia). The
onset time for a sensory block was defined as the time
elapsed between the end of the block procedure and the
moment when the pinprick test yielded a score of 2.
Failure to reach a score of 2 within 30 min of intersca-
lene block was considered to be block failure. Motor
blockade was determined by loss of shoulder abduction
(deltoid sign) and was objectively assessed on a 3-point
rating scale: 0, normal movement; 1, diminished move-
ment; and 2, no movement.
Complications, such as hematoma, Horner’s syndrome,
hoarseness, respiratory distress and a decrease in SpO2
of more than 5 %, were also assessed during this period.
Before and 30 min after the block, an independent ob-
server evaluated ipsilateral hemidiaphragmatic move-
ment on deep inspiration by ultrasonography using a 5–
2 MHz broadband curved array transducer (SonoSite,
Inc., Bothell, Wash). Patients were examined in the up-
right sitting position and scanned from a low intercostal
or subcostal approach using the liver or spleen as an
acoustic window [3]. Normal caudad movement with
deep inspiration was considered to be no paresis,
whereas no movement or paradoxical cephalad move-
ment was designated as paresis.
General anesthesia was induced with propofol (target
controlled infusion 3–5 μg/ml), fentanyl (1.5 ~ 2.5 μg/kg)
and cisatracurium (0.15 mg/kg) and maintained with
propofol (target controlled infusion 3–5 μg/ml) and
remifentanil (continuous infusion 0.05–0.3 μg/kg/min).
Patients were intubated and ventilated with an oxygen/
air admixture. Anesthesia management was left to the
discretion of the attending anesthesiologist. No other an-
algesics were administered intraoperatively.
All patients received parecoxib 40 mg bid for the first
two days after surgery. Tramadol 100 mg or pethidine
50 mg was given as rescue analgesics for numerical rat-
ing pain scale (NRPS) ≥4 or by the patient’s request.
Patients were instructed to rate their pain using an 11-
point NRPS ranging from 0 to 10 (0, no pain; 10, worst
imaginable pain). NRPS of rest pain was measured be-
fore the block, right before discharge from the PACU
and at 4, 8, 24 h after the block. The timing and dosage
of analgesics were recorded. Twenty-four hours after the
block, patients were questioned for NRPS of the worst
pain, time of the first shoulder pain, sleep quality (0 = no
sleep disturbance because of pain, 1 = sleep disturbance
because of pain) and satisfaction with the interscalane
block (0–10, 0 = very unsatisfied; 10 = very satisfied).
The blinded investigator recorded grip strength in the op-
erative limb using the same Jamar dynamometer before the
administration of intravenous sedation, right before dis-
charge from the PACU and at 4, 8 and 24 h after the block.
The patient was telephone interviewed if they suffered
a late complication such as scapula alata, nerve injury
and pain along the medial border of scapula or radiating
to the arm and forearm related to interscalene block
after more than one year since discharge from hospital.
The primary outcome was onset time. Our research
hypothesis was that compared with low concentration/
high volume group, high concentration/low volume
group would result in a shorter onset time. According to
our preliminary test, the onset time for 10 mL of 0.5 %
ropivacaine is 10 ± 5 min. We considered a time differ-
ence of 50 % as being clinically relevant. To obtain a 2-
tailed α error of 0.05 and a statistical power of 0.9, the
calculated sample size was 27 patients per group. We re-
cruited 33 patients per group in anticipation of 20 % po-
tential dropouts.
Statistical analysis
The SPSS version 20.0 (SPSS, Inc., Chicago, USA) was
used. The normality of the continuous data was first
assessed with the Kolmogorov-Smirnov test. Normally
distributed variables were expressed as the mean ± SD
and compared between groups using one way analysis of
variance (ANOVA) with an LSD post hoc test. Non-
normally distributed variables were expressed as the me-
dian (range) and analysed using the Kruskal-Wallis H
test. Categorical variables were expressed as the number
(%) and compared between groups using a Pearson test.
Kaplan-Meier survival curves were constructed (survival
was equivalent to unsuccessful block). The log-rank test
was used to detect differences in block onset times
among groups. P < 0.05 was considered statistically
significant.
Results
From December 2013 to February 2014, 99 patients were
enrolled in the study. Four patients were excluded either
due to the variation from the protocol or the changes of
the procedure. Figure 1 presented the allocation process
according to the Consolidated Standards of Reporting
Trials (CONSORT) statement. No differences in patient
demographic data were observed among the 3 groups
(Table 1).
The onset of sensory and motor blockade was shorter
in patients receiving higher concentrations of ropiva-
caine (P < 0.05, Fig. 2). All patients received full sensory
block when the 30-min follow-up ended. The median
(range) sensory blockade onset times, which were 5 (5–20)
minutes, 10 (5–20) minutes, and 20 (5–30) minutes for
Group 0.75, 0.5 and 0.25 respectively. They were statisti-
cally significantly different (P = 0.000 by log-rank test).
Group 0.75 had faster onset time than group 0.5 (P = 0.013
by log-rank test). The median (range) of motor blockade
onset times of Group 0.75 and Group 0.5 were 10 (5–25)
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minutes and 15 (5–30) minutes, respectively. One patient
from Group 0.5 and 20 patients from Group 0.25 did
not achieve complete motor blockade when the 30-
min follow-up ended. These differences were also
significantly different (P = 0.000 by log-rank test)
among the three groups. There was no significant
difference between group 0.75 and group 0.5 after
further comparison.
Baseline diaphragmatic movements were similar and
normal in all patients. Thirty minutes after ISBPB, ab-
sent or paradoxical diaphragmatic movements were ob-
served in 58 % of Group 0.75, 69 % of Group 0.5, and
70 % of Group 0.25 (P = 0.516), respectively.
In Group 0.25, one patient developed Horner’s syn-
drome 30 min after ISBPB. No patients suffered from re-
spiratory distress, hypoxia, post-block hoarseness,
hematoma or LA toxicity.
The pain scores (NRPS) measured before the block,
right before discharge from the PACU, and 4, 8, 24 h
after block and the worst pain were similar in all groups.
The percentages of the worst pain scores over 4, rescue
analgesia, sleep quality, time to first report of pain and
satisfaction scores were also comparable among the 0.75,
0.5, and 0.25 groups. (Table 2)
The preoperative values of hand grip strength were
used as 100 %, and the average of quantitative preopera-
tive grip strength was 24.0 ± 11.5 kg, 27.6 ± 12.9 kg and
26.6 ± 9.6 kg for Group 0.75, Group 0.5 or Group 0.25,
respectively. The recovery time of the hand grip strength
of the blocked arm was similar among the three groups
during the study period. The strength of the hand on the
blocked side decreased to 41, 32 and 36 % in the PACU.
At 4 h after the block, the strength recovery was 48, 46
and 42 % in Group 0.75, Group 0.5 or Group 0.25, re-
spectively. At 8 h after the block, the hand strength was
70, 52 and 57 % in Group 0.75, Group 0.5 or Group
0.25, respectively. At 24 h after the block, the hand grip
strength restored to 98, 95 and 91 %. (Fig. 3)
Over 85 % of the patients completed the telephone
interview and none reported a late and severe complica-
tion related to interscalene block such as scapula alata.
Discussion
This prospective, randomized, double blind trial com-
pared the clinical effects of 3 combinations of volumes
and concentrations of ropivacaine (6.7 ml of 0.75 %,
10 ml of 0.5 % and 20 ml of 0.25 %) for ISBPB. The re-
sults demonstrated a faster onset of complete sensory
and motor blockade for the higher concentration groups.
No intergroup differences were found in terms of the
block success rate, postoperative analgesia, decrease in
hand grip strength and incidence of hemi-diaphragmatic
paresis. Interscalene block is one of the most reliable
and most commonly performed regional techniques for
arthroscopic shoulder surgery. Clinicians prefer to
choose the regimen with fast onset, high success rate, re-
liable analgesic effect, early recovery of hand motor and
good preservation of diaphragm function. According to
our results, except onset time, there was no significant
difference among the three groups in these aspects. To
facilitate operation and shorten OR turnover time, ropi-
vacaine 0.75 % seems to be more preferable.
Both concentration and volume of LA were crucial
factors for the onset of block. In theory, an increased LA
Fig. 1 Allocation process according to CONSORT








Age, yr 45 ± 13 44 ± 16 49 ± 16 0.416
Height, cm 165 ± 9 169 ± 11 168 ± 7 0.211
Weight, kg 67 ± 13 77 ± 13 71 ± 11 0.219
BMI, kg/m2 24.3 ± 3.5 24.8 ± 2.6 25.3 ± 3.3 0.478
Sex (male/female), n 15/18 17/12 24/9 0.079
Surgical type (Bankart repair/Rotator cuff repair), n 8/25 7/22 7/26 0.655
Surgical time, min 101 ± 40 87 ± 32 103 ± 40 0.197
Remifentanil consumption, μg/kg/min 0.07 ± 0.03 0.08 ± 0.03 0.07 ± 0.03 0.619
Continuous variables are presented as the means ± SDs; categorical variables are presented as counts
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Fig. 2 Kaplan-Meier survival curves constructed using survival as being equivalent to an “unsuccessful block.” The onset of sensory (a) and motor
(b) blockade was shorter in patients receiving higher concentration of ropivacaine (P = 0.000 by log-rank test)
Table 2 Outcomes of pain control among the 3 groups
Group 0.75 Group 0.5 Group 0.25 P
NRPS in the PACU 0 (0–2) 0 (0–1) 0 (0–0) 0.581
NRPS 4 h after ISB 0 (0–2) 0 (0–1) 0 (0–3) 0.771
NRPS 8 h after ISB 0 (0–3) 0 (0–3) 0 (0–3) 0.211
NRPS 24 h after ISB 1 (0–6) 1 (0–5) 0 (0–7) 0.439
Worst pain score 3 (0–6) 3 (0–7) 3 (0–7) 0.882
Percentage of worst pain score over 4 (n,%) 11/33 (33 %) 6/29 (21 %) 12/33 (36 %) 0.372
Sleep disturbance because of pain (n,%) 6/33 (18 %) 2/29 (7 %) 5/33 (15 %) 0.416
Satisfaction score 9.2 ± 1.3 8.9 ± 1.2 9.4 ± 1.0 0.167
Data are the mean ± SD, median (range) or numbers (incidence)
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concentration can shorten the onset time because of the
improved neural penetration by LA molecules [12], and
an increased volume can shorten the onset time by pro-
moting LA diffusion around neural structures [10].
However, how the volume/concentration ratio in a fixed
dose affects the regional anesthetic block remains un-
clear. The results of previous studies on the onset time
of the same dose of LA diluted in different volumes for
nerve blocks [6–11] were inconsistent, which might be
attributed to volume/concentration ratio and the follow-
ing factors as well.
First, the type of the tissue surrounding the target
nerve is essential for the onset of a nerve block. It has
been suggested that the LA volume was the main deter-
minant of the onset time for a single-injection axillary
block [10], where only loose connective tissue sur-
rounded the brachial plexus. For Labat sciatic nerve
block, where the sciatic nerve was surrounded by com-
pact structures with minimal compliant, such as bone
and muscles, a higher concentration seemed to be more
effective [7].
Second, multiple injection technique may eliminate vol-
ume/concentration ratio effect. For example, using a sin-
gle injection technique, with a fixed dose of LA diluted to
different volumes, volume/concentration ratio affected the
onset of axillary block [10]. But using a multiple injection
technique, the onsets of an axillary block were similar
among different volume/concentration ratio groups [9]. A
study of single injection Labat sciatic nerve block showed
various volume/concentration combinations resulted in
different onset times [7]. While using a double injection
technique, the onset of Labat sciatic nerve block did not
differ with the different volume/concentration ratio [6].
Multiple injection facilitated the injection of LA targeting
at each component of the peripheral nerve and resulted in
a better distribution of LA solution around each individual
nerve, with this distribution of LA, when proper doses
were used, the anatomic characters became secondary to
the injection technique and the effect of concentration/
volume ratio was weakened. Study with a multiple injec-
tion technique in other area, such as humeral canal block
[11], also showed no difference with different volume/
concentration combinations.
Analgesia for shoulder surgery requires blockade of
the C5-6 nerve roots or superior trunk, which is divided
into suprascapular, axillary and lateral pectoral nerves
innervating the shoulder [2]. Therefore, we used a single
injection technique targeting only the C5-6 roots with
the guidance of ultrasound and a nerve stimulator. We
found that increasing the ropivacaine concentration
from 0.25 to 0.5 or 0.75 % resulted in a faster onset of
both sensory and motor blocks. At the level of the inter-
scalene groove, the scalene muscles and their investing
fascia provided a well-demarcated potential space in
which LA could be injected [13]. The anatomic aspects
of tissue surrounding the C5-6 roots might explain why
a higher concentration led to faster onset.
Previous studies have shown that 50 mg of low dose
ropivacaine diluted into 0.75 % of 6.7 ml [3], 0.5 % of
10 ml [4] and 0.25 % of 20 ml [5] were proved to be ef-
fective in different studies for at least two hours after
the shoulder surgery. In our study, all three groups had
satisfactory shoulder analgesia for at least 8 h after the
interscalane nerve block with 50 mg of ropivacaine. Be-
tween 8 and 24 h after the block, 30 % of patients expe-
rienced their worst pain score over 4, and almost all of
these patients were confirmed to have massive rotator
cuff tear. It suggested that for surgeries of massive rota-
tor cuff tear, better pain control including a relatively
large dose of LA, multimodal analgesia or a continuous
interscalene block should be selected according to the
laceration degree of the rotator cuff.
Fig. 3 Summary of the averages of the hand strength changes in patients receiving 0.75 %, 0.5 % and 0.25 % ropivacaine. Measurements were
made preoperatively (T0), in the PACU (T1), and 4 h (T2), 8 h (T3) and 24 h (T4) after the interscalene block. The values represent the mean ± sd
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Our study was the first to compare the incidence of
hemidiaphragmatic paresis with same dose of LA diluted
in different volumes. The phrenic nerve arises mainly
from the C4 root, with variable contributions from C3
and C5. It courses caudally between the ventral surface of
the anterior scalene muscle and prevertebral fascial layer
that covers this muscle and is therefore separated from
the brachial plexus only by a thin fascial layer. As a result,
its block in ISBPB can be explained by the proximity to
the brachial plexus or to the cephalad spread of local
anesthetic to the C3–5 roots of the cervical plexus before
their formation of the phrenic nerve [4]. On the basis of
the anatomic characteristics, it had been suggested that re-
ducing the dose of LA [4, 14–16] or moving the injection
site farther from the C3-5 roots [17] may be able to lower
the incidence. In our study, with the same LA dosage and
targeting nerve, hemidiaphragmatic paresis occurred in
58-70 % of patients 30 mins after block, with no statistical
difference among the three groups, and the incidence was
similar to those reported in previous studies [4].
Our study has some limitations. First, the blockade
was performed by an anesthesiologist experienced with
interscalane block; therefore, our findings should be
carefully applied to other conditions as this was a low
dose study with as little as 6.7 ml of LA in one of the
groups. Second, the result obtained from ropivacaine
might not be true for other LAs. Third, compared to
European population, the presented (low) BMI is con-
spicuous and relevant as for blockade effect with very
low volumes of local anesthetics. Therefore, results can-
not thoroughly be transferred. Forth, although the ratio
of male and female patients was not significantly differ-
ent among groups, there is an imbalance in the dis-
tribution of the gender of patients, so that an influence
of gender may not be excluded. At last, although a com-
mon approach to perform ultrasound-guided int-
erscalene block is to image the brachial plexus in short
axis and to insert the needle using the in-plane approach
[3, 4, 14, 16–18], this technique bears the risk of injuring
the small branches of the brachial plexus associated with
the middle scalene muscle, such as the dorsal scapular
and long thoracic nerves [19, 20]. Unfortunately, neither
outcome data describing injury to these nerves, nor tech-
nical guideline to ensure avoidance of this event is avail-
able. It is safer to follow a shallower needle trajectory to
avoid entering the bulk of middle scalene muscle, visualize
these nerves by ultrasound, and use a peripheral nerve
stimulator to identify proximity to these nerves. To con-
clude, extra caution should be taken using short-axis in-
plane brachial plexus block to avoid the nerve damage.
Conclusion
In summary, the present study shows that ropivacaine
50 mg given around interscalene brachial plexus as 0.25,
0.5 or 0.75 % solution before arthroscopic shoulder surgery
produces comparable blockade with few side effects, while
0.75 % seems to be more preferable as it is associated with
faster onset time.
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